AUPH Q2 2017 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$329,000+498.2% YoY

Gross Profit

-$7M-2060.2% margin

Operating Income

-$10M-3054.4% margin

Net Income

-$2M-729.2% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

+961.3%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$978,000

Balance Sheet

Total Assets

$208M

Total Liabilities

$29M

Stockholders' Equity

$178M

Cash & Equivalents

$180M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$329,000	$55,000	+498.2%
Gross Profit	-$7M	$54,000	-12651.9%
Operating Income	-$10M	-$5M	-120.8%
Net Income	-$2M	-$3M	+26.8%